Bruker Cellular Analysis, Inc. Quarterly Debt-to-equity in % from Q1 2021 to Q2 2023

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Bruker Cellular Analysis, Inc. quarterly Debt-to-equity history and growth rate from Q1 2021 to Q2 2023.
Bruker Cellular Analysis, Inc. Debt-to-equity for the quarter ending June 30, 2023 was 65.1 %, a 68.8% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q2 2023	65.1	+26.5	+68.8%	Jun 30, 2023
Q1 2023	59.8	+25	+72%	Mar 31, 2023
Q4 2022	46.1	+14.6	+46.2%	Dec 31, 2022
Q3 2022	41.2	+13.5	+48.8%	Sep 30, 2022
Q2 2022	38.6	+15	+63.4%	Jun 30, 2022
Q1 2022	34.8	+7.59	+28%	Mar 31, 2022
Q4 2021	31.5			Dec 31, 2021
Q3 2021	27.7			Sep 30, 2021
Q2 2021	23.6			Jun 30, 2021
Q1 2021	27.2			Mar 31, 2021

* An asterisk sign (*) next to the value indicates that the value is likely invalid.